Recent BioUtah News & Events

Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry

ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners

Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization

SALT LAKE CITY, February 26, 2026— ARUP Laboratories, a leader in diagnostic medicine and the largest nonprofit reference laboratory in the U.S., today announced the launch of a new Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners. The Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating […]

Twelve rising startups have been selected to present their innovations to investors during the 2026 Entrepreneur & Investor Life Sciences Summit on March 12, sponsored by Wilson Sonsini. Salt Lake City, February 20, 2026—BioUtah, Utah’s trade association dedicated solely to the life sciences, in partnership with Brigham Young University’s (BYU) Technology Transfer Office and College […]

RadSep, Inc., a subsidiary of IBC Advanced Technologies, Inc., provides state-of-the-art purification technology and novel chelators for medical radioisotopes and their precursors (Ac-225, Ra-224, Ra-225, Ra-226, Ra-228, Th-228, Th-232, Pb-212, Cu-67, and more). RadSep offers Molecular Recognition Technology™ (MRT™) resins that are extremely selective, stable and simple to use. First-pass recoveries and purities of 99.9+% […]

CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution

Cytiva Sponsors Operational Excellence Case Study Competition

Featuring exhibits from over 20 local companies, including medical device, diagnostics, and biotech companies.

First podium presentation of IDE Clinical Trial Data of Novel Embolic Device to Treat Cancer

Senator Lee’s Deputy chief of staff Justin Anthony yesterday toured the new James LeVoy Sorenson Center for Medical Innovation (SCMI) at the University of Utah. The four-story, nearly 60,000-square-foot facility, led by Executive Director, Mark Paul, features advanced prototyping labs, a clinical bio-tissue surgery suite, and incubator spaces designed to foster, develop, and commercialize next-generation […]

Rarity Bioscience Announces That ARUP Laboratories Has Become the First U.S. Reference Lab To Validate Its Ultrasensitive superRCA Assay

Strategic investment in private AI infrastructure positions Owlet to compound value from its growing base of proprietary infant wellness data.

Nathan Tenney, Aide to Rep. Maloy Tours Utah Life Sciences Companies

Behavioral Health Assessment Using Vocal Biomarkers

Wasatch Health Announces Expanded Investment Platform to Accelerate Life Sciences Growth in Utah and the Mountain West

Report draws on Owlet’s massive infant sleep dataset, one of the world’s largest, to reveal how babies sleep – evaluating bedtimes, wake-ups, sleep stretches, and biometric trends

Peer-reviewed Phase 2 Results Inform Ongoing Phase 3/Pivotal Trial of Celeste® in Parkinson’s Disease

SPARC Health, a collaborative effort between Park City Angels (PCA), BioUtah, BioHive, in partnership with Governor’s Office of Economic Opportunity (GOEO), announced applications are now open for its second cohort program.

Taking place on March 12, 2026, at the Hilton Salt Lake City Center, the competition provides early-stage healthcare companies with a premier platform to showcase innovations to experienced investors and industry leaders.

Check out the photo gallery from the 2026 JP Morgan Healthcare conference in San Francisco.

The purchase is expected to expand Haemonetics’ impact in fast-growing markets for structural heart and endovascular procedures.

State-of-the-art, multi-modality breast biopsy system slated to be in the market in early 2026

DiscGenics Treats First Patient in Phase 3 Clinical Trial of IDCT (Rebonuputemcel) for Symptomatic Mild-to-Moderate Lumbar Degenerative Disc Disease

Published in the journal PREGNANCY, the PRIME Study demonstrates significant improvements in neonatal outcomes with early risk screening and targeted interventions.

Fluidx GPX Embolic Device Pivotal Trial Completes Enrollment

Dr. Mark Davis, discoverer of the first T-cell receptor genes and Stanford Professor, to advise the Company on immunological strategies for its novel cancer treatment platform.

Wasatch BioLabs Announces Co-Marketing Agreement With Agilent to Advance Native-Read Targeted Sequencing

As we look back at 2025, we’re thankful for the progress our team and partners helped drive this year.

The New England Journal of Medicine Publishes Phase 1/2 Study of Denali Therapeutics’ Tividenofusp Alfa (DNL310) for Hunter Syndrome (MPS II)

2025 marked a year of significant progress of reached milestones and successes for Bloom Surgical

A microbiologist, Adam Barker, PhD, was ARUP’s chief scientific officer and director of Research and Development before being named chief operations officer—now adds Reference Business Unit president to his title.